CTI BIOPHARMA

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
2014-01-01
Employees
-
Market Cap
-
Website
http://www.ctibiopharma.com/

Phase II CT-2103/Carboplatin in Ovarian Cancer

Phase 2
Completed
Conditions
First Posted Date
2003-10-06
Last Posted Date
2008-09-22
Lead Sponsor
CTI BioPharma
Target Recruit Count
82
Registration Number
NCT00069901
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Baptist Regional Cancer Center, Knoxville, Tennessee, United States

๐Ÿ‡บ๐Ÿ‡ธ

Resource Center for Gynecology/ Oncology, Kansas City, Missouri, United States

๐Ÿ‡บ๐Ÿ‡ธ

California Cancer Care, Greenbrae, California, United States

and more 14 locations

Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma

First Posted Date
2003-05-12
Last Posted Date
2015-01-19
Lead Sponsor
CTI BioPharma
Target Recruit Count
800
Registration Number
NCT00060671
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Arizona Clinical Research Center, Tucson, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Sutter Health Western Division Cancer Research Group, Greenbrae, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Kenmar Research Institute, Los Angeles, California, United States

and more 35 locations

Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

First Posted Date
2003-05-12
Last Posted Date
2015-01-19
Lead Sponsor
CTI BioPharma
Target Recruit Count
30
Registration Number
NCT00060684
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Greater Baltimore Medical Center, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

MD Anderson Cancer Center, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Arizona Clinical Research Center, Tucson, Arizona, United States

and more 1 locations

Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Phase 3
Terminated
Conditions
First Posted Date
2003-02-06
Last Posted Date
2020-10-05
Lead Sponsor
CTI BioPharma
Registration Number
NCT00054210
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Clinical Trials and Research Associates, Incorporated, Montebello, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Omni Healthcare, PA, Melbourne, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Columbia Comprehensive Cancer Care Clinic, Columbia, Missouri, United States

and more 31 locations

Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Phase 3
Terminated
Conditions
First Posted Date
2003-02-06
Last Posted Date
2020-10-05
Lead Sponsor
CTI BioPharma
Registration Number
NCT00054197
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Cooper Green Hospital, Birmingham, Alabama, United States

๐Ÿ‡บ๐Ÿ‡ธ

Western Washington Oncology, Incorporated, Olympia, Washington, United States

๐Ÿ‡บ๐Ÿ‡ธ

New York Oncology Hematology, P.C. - Latham, Latham, New York, United States

and more 7 locations

Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2003-02-06
Last Posted Date
2020-10-05
Lead Sponsor
CTI BioPharma
Target Recruit Count
350
Registration Number
NCT00054184
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Saint Joseph Oncology, Incorporated, Saint Joseph, Missouri, United States

๐Ÿ‡บ๐Ÿ‡ธ

Gabrail Cancer Center - Canton Office, Canton, Ohio, United States

๐Ÿ‡บ๐Ÿ‡ธ

Montana Cancer Specialists, Missoula, Montana, United States

and more 30 locations

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

First Posted Date
2003-01-27
Last Posted Date
2020-10-05
Lead Sponsor
CTI BioPharma
Registration Number
NCT00020969
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Lynn Regional Cancer Center West, Boca Raton, Florida, United States

and more 5 locations

Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma

First Posted Date
2003-01-27
Last Posted Date
2020-10-05
Lead Sponsor
CTI BioPharma
Registration Number
NCT00017069
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mountain States Tumor Institute - Boise, Meridian, Idaho, United States

๐Ÿ‡บ๐Ÿ‡ธ

Texas Cancer Care, Fort Worth, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Rocky Mountain Cancer Centers - Midtown, Denver, Colorado, United States

and more 7 locations
ยฉ Copyright 2024. All Rights Reserved by MedPath